Miles Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$964K Buy
12,900
+188
+1% +$13K 1.04% 21
2019
Q4
$826K Sell
12,712
-390
-3% -$25.4K 0.66% 38
2019
Q3
$830K Sell
13,102
-584
-4% -$38.2K 0.68% 39
2019
Q2
$925K Sell
13,686
-208
-1% -$13.7K 0.75% 35
2019
Q1
$903K Sell
13,894
-78
-0.6% -$5.18K 0.78% 38
2018
Q4
$874K Buy
13,972
+2,781
+25% +$194K 0.86% 27
2018
Q3
$864K Sell
11,191
-1,243
-10% -$93.9K 0.7% 42
2018
Q2
$881K Sell
12,434
-4,287
-26% -$303K 0.54% 43
2018
Q1
$1.26M Sell
16,721
-105
-0.6% -$8.35K 0.7% 27
2017
Q4
$1.21M Sell
16,826
-18
-0.1% -$1.37K 0.7% 33
2017
Q3
$1.36M Sell
16,844
-3,688
-18% -$282K 0.77% 17
2017
Q2
$1.45M Buy
20,532
+4,559
+29% +$303K 0.78% 16
2017
Q1
$1.08M Sell
15,973
-92
-0.6% -$6.47K 0.6% 38
2016
Q4
$1.15M Buy
16,065
+1,184
+8% +$88K 0.7% 31
2016
Q3
$1.18M Buy
14,881
+2,376
+19% +$193K 0.8% 24
2016
Q2
$1.04M Buy
+12,505
New +$1.11M 0.71% 22

Other funds holding GILD

Miles Capital's GILD Position: Q1 2020 in Review

Miles Capital increased its Gilead Sciences (GILD) stake by 1.5% in Q1 2020, buying an estimated $13K and bringing the position to 12,900 shares worth $964K. The position accounts for 1.04% of the portfolio, ranked #21.

Miles Capital first reported a position in GILD in Q2 2016 and has held it in 16 quarters since. The position peaked at $1.45M in Q2 2017. 1,642 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Miles Capital held 12,900 shares of Gilead Sciences worth $964K as of Q1 2020.
  • Miles Capital bought 188 Gilead Sciences shares in Q1 2020, an estimated $13K.
  • Gilead Sciences made up 1.04% of Miles Capital's portfolio in Q1 2020, its #21 holding.
  • Miles Capital first reported a position in Gilead Sciences in Q2 2016 and has held it in 16 quarters since.
  • Miles Capital's Gilead Sciences position peaked at $1.45M in Q2 2017.
  • 1,642 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.